Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., USE OF CORONARY ANGIOGRAPHY AND REVASCULARIZATION PROCEDURES FOLLOWING ACUTE MYOCARDIAL-INFARCTION - A EUROPEAN PERSPECTIVE, European heart journal, 19(9), 1998, pp. 1348-1354
Authors:
WOODS KL
KETLEY D
LOWY A
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., BETA-BLOCKERS AND ANTITHROMBOTIC TREATMENT FOR SECONDARY PREVENTION AFTER ACUTE MYOCARDIAL-INFARCTION - TOWARDS AN UNDERSTANDING OF FACTORSINFLUENCING CLINICAL-PRACTICE, European heart journal, 19(1), 1998, pp. 74-79
Citation: D. Ketley et Kl. Woods, CLINICAL EFFECTS OF ANTICOAGULANTS IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - USE OF ANTICOAGULANTS IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION IN EUROPE VARIES, BMJ. British medical journal, 314(7075), 1997, pp. 223-223
Citation: A. Reikvam et D. Ketley, THROMBOLYTIC ELIGIBILITY IN ACUTE MYOCARDIAL-INFARCTION PATIENTS ADMITTED TO NORWEGIAN HOSPITALS, International journal of cardiology, 61(1), 1997, pp. 79-83
Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROVICZ A
LOWY A
REIKVAM A
SCHILLING J
GOMES RS
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., TRANSLATION OF CLINICAL-TRIALS INTO PRACTICE - A EUROPEAN POPULATION-BASED STUDY OF THE USE OF THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION, Lancet, 347(9010), 1996, pp. 1203-1207
Citation: D. Ketley et Kl. Woods, SELECTION FACTORS FOR THE USE OF THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL-INFARCTION - A POPULATION-BASED STUDY OF CURRENT PRACTICE IN THE UNITED-KINGDOM, British Heart Journal, 74(3), 1995, pp. 224-228
Citation: D. Ketley et Kl. Woods, IMPACT OF CLINICAL-TRIALS ON CLINICAL-PRACTICE - EXAMPLE OF THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION, Lancet, 342(8876), 1993, pp. 891-894